vaccine

The CDC's planning guidance for states includes multiple scenarios for the rollout of a vaccine this year, including possibly having a limited number of doses available in October and November.

Millions of Americans are counting on a COVID-19 vaccine to curb the global pandemic and return life to normal.While one or more options could be…

Scientists at Cuba's major biotech institute say their coronavirus vaccine looks promising, but trial results won't be ready until next year.

The World Health Organization's Tedros Adhanom Ghebreyesus says he fears that without global cooperation ensuring equal access to COVID-19 vaccines, some countries could resort to hoarding.

The virus might eventually behave more like the common cold, according to Vineet Menachery, a coronavirus researcher at the University of Texas Medical Branch.

Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.

For a world crippled by the coronavirus, salvation hinges on a vaccine.But in the United States, where at least 4.6 million people have been infected and…

Public health officials say a promising coronavirus vaccine is on its way in 2021. But does that matter if only half of Americans say they're willing to get such a vaccination?

Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.

The vaccine trial that Vice President Mike Pence kicked off in Miami on Monday gives the United States the tiniest chance of being ready to vaccinate…